Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 11/13/2024 | 8.56 M | $3.49 B | 100.00% | 9.62% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 8.56 M | $3.49 M | 100.00% | 9.62% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 5.08 M | $2.07 M | 46.37% | 5.71% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 5.00 M | $2.04 M | 100.00% | 5.62% |
| VIVO CAPITAL, LLC | 11/13/2024 | 4.47 M | $1.82 M | 28.82% | 5.03% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.00 M | $1.63 M | 100.00% | 4.50% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.82 M | $1.15 M | 0.00% | 3.17% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 2.25 M | $917,775 | 100.00% | 2.53% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 1.98 M | $807,315 | 100.00% | 2.23% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 1.47 M | $600,837 | 100.00% | 1.66% |
| VANGUARD GROUP INC | 11/13/2024 | 1.14 M | $464,394 | 0.00% | 1.28% |
| LPL FINANCIAL LLC | 11/08/2024 | 466,005 | $190,083 | 448.24% | 0.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 402,398 | $164,138 | 40.83% | 0.45% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 93,424 | $38,108 | 0.08% | 0.11% |
| BLEAKLEY FINANCIAL GROUP, LLC | 10/16/2024 | 80,000 | $32,632 | 100.00% | 0.09% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 73,975 | $30,000 | 566.80% | 0.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 71,821 | $29,296 | 100.00% | 0.08% |
| XTX TOPCO LTD | 11/14/2024 | 70,784 | $28,873 | 100.00% | 0.08% |
| STATE STREET CORP | 11/14/2024 | 43,936 | $17,921 | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 41,249 | $16,826 | 100.00% | 0.05% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 23,266 | $9,490 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 22,782 | $9,295 | 23.25% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 18,800 | $7,669 | 0.00% | 0.02% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 10/25/2024 | 15,500 | $6,322 | 0.00% | 0.02% |
| CREATIVE PLANNING | 10/11/2024 | 10,231 | $4,173 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 332 | $135 | 48.88% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 207 | $84 | 195.71% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ROSALIND ADVISORS, INC. | 10/30/2024 | 0 | $0 | -100.00% | 0.00% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Unicycive Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
Octagon Capital Advisors LP: 8.56 M
GREAT POINT PARTNERS LLC: 8.56 M
Logos Global Management LP: 5.08 M
Walleye Capital LLC: 5 M
Vivo Capital, LLC: 4.47 M
SILVERARC CAPITAL MANAGEMENT, LLC: 4 M
52.60% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.83 M shares in the last 24 months. This purchase volume represents approximately $31.38 M in transactions.